Viral Vector and Plasmid DNA-Global Market Status and Trend Report 2016-2026

Table of Contents

Chapter 1 Overview of Viral Vector and Plasmid DNA

• 1.1 Definition of Viral Vector and Plasmid DNA in This Report
• 1.2 Commercial Types of Viral Vector and Plasmid DNA
  • 1.2.1 Plasmid DNA
  • 1.2.2 Viral Vector
• 1.3 Downstream Application of Viral Vector and Plasmid DNA
  • 1.3.1 Cancer
  • 1.3.2 Virus Infection
  • 1.3.3 Hereditary Disease
• 1.4 Development History of Viral Vector and Plasmid DNA
• 1.5 Market Status and Trend of Viral Vector and Plasmid DNA 2016-2026
  • 1.5.1 Global Viral Vector and Plasmid DNA Market Status and Trend 2016-2026
  • 1.5.2 Regional Viral Vector and Plasmid DNA Market Status and Trend 2016-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Viral Vector and Plasmid DNA 2016-2021
• 2.2 Production Market of Viral Vector and Plasmid DNA by Regions
  • 2.2.1 Production Volume of Viral Vector and Plasmid DNA by Regions
  • 2.2.2 Production Value of Viral Vector and Plasmid DNA by Regions
• 2.3 Demand Market of Viral Vector and Plasmid DNA by Regions
• 2.4 Production and Demand Status of Viral Vector and Plasmid DNA by Regions
  • 2.4.1 Production and Demand Status of Viral Vector and Plasmid DNA by Regions 2016-2021
  • 2.4.2 Import and Export Status of Viral Vector and Plasmid DNA by Regions 2016-2021

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Viral Vector and Plasmid DNA by Types
• 3.2 Production Value of Viral Vector and Plasmid DNA by Types
• 3.3 Market Forecast of Viral Vector and Plasmid DNA by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Viral Vector and Plasmid DNA by Downstream Industry
• 4.2 Market Forecast of Viral Vector and Plasmid DNA by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Viral Vector and Plasmid DNA

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Viral Vector and Plasmid DNA Downstream Industry Situation and Trend Overview

Chapter 6 Viral Vector and Plasmid DNA Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Viral Vector and Plasmid DNA by Major Manufacturers
• 6.2 Production Value of Viral Vector and Plasmid DNA by Major Manufacturers
• 6.3 Basic Information of Viral Vector and Plasmid DNA by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Viral Vector and Plasmid DNA Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Viral Vector and Plasmid DNA Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Viral Vector and Plasmid DNA Major Manufacturers Introduction and Market Data

• 7.1 Brammer Bio
  • 7.1.1 Company profile
  • 7.1.2 Representative Viral Vector and Plasmid DNA Product
  • 7.1.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of Brammer Bio
• 7.2 Oxford BioMedica
  • 7.2.1 Company profile
  • 7.2.2 Representative Viral Vector and Plasmid DNA Product
  • 7.2.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of Oxford BioMedica
• 7.3 Cobra Biologics
  • 7.3.1 Company profile
  • 7.3.2 Representative Viral Vector and Plasmid DNA Product
  • 7.3.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of Cobra Biologics
• 7.4 FinVector
  • 7.4.1 Company profile
  • 7.4.2 Representative Viral Vector and Plasmid DNA Product
  • 7.4.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of FinVector
• 7.5 Lonza
  • 7.5.1 Company profile
  • 7.5.2 Representative Viral Vector and Plasmid DNA Product
  • 7.5.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of Lonza
• 7.6 BioReliance
  • 7.6.1 Company profile
  • 7.6.2 Representative Viral Vector and Plasmid DNA Product
  • 7.6.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of BioReliance
• 7.7 MolMed
  • 7.7.1 Company profile
  • 7.7.2 Representative Viral Vector and Plasmid DNA Product
  • 7.7.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of MolMed
• 7.8 FUJIFILM Diosynth Biotechnologies
  • 7.8.1 Company profile
  • 7.8.2 Representative Viral Vector and Plasmid DNA Product
  • 7.8.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of FUJIFILM Diosynth Biotechnologies
• 7.9 UniQure
  • 7.9.1 Company profile
  • 7.9.2 Representative Viral Vector and Plasmid DNA Product
  • 7.9.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of UniQure
• 7.10 Aldevron
  • 7.10.1 Company profile
  • 7.10.2 Representative Viral Vector and Plasmid DNA Product
  • 7.10.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of Aldevron
• 7.11 Richter-Helm
  • 7.11.1 Company profile
  • 7.11.2 Representative Viral Vector and Plasmid DNA Product
  • 7.11.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of Richter-Helm
• 7.12 Eurogentec
  • 7.12.1 Company profile
  • 7.12.2 Representative Viral Vector and Plasmid DNA Product
  • 7.12.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of Eurogentec
• 7.13 OBiO Technology
  • 7.13.1 Company profile
  • 7.13.2 Representative Viral Vector and Plasmid DNA Product
  • 7.13.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of OBiO Technology
• 7.14 Yposkesi
  • 7.14.1 Company profile
  • 7.14.2 Representative Viral Vector and Plasmid DNA Product
  • 7.14.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of Yposkesi
• 7.15 Cell and Gene Therapy Catapult
  • 7.15.1 Company profile
  • 7.15.2 Representative Viral Vector and Plasmid DNA Product
  • 7.15.3 Viral Vector and Plasmid DNA Sales, Revenue, Price and Gross Margin of Cell and Gene Therapy Catapult
• 7.16 MassBiologics
• 7.17 Biovian
• 7.18 VGXI
• 7.19 Gene Synthesis
• 7.20 PlasmidFactory
• 7.21 Jikai Gene

Chapter 8 Upstream and Downstream Market Analysis of Viral Vector and Plasmid DNA

• 8.1 Industry Chain of Viral Vector and Plasmid DNA
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Viral Vector and Plasmid DNA

• 9.1 Cost Structure Analysis of Viral Vector and Plasmid DNA
• 9.2 Raw Materials Cost Analysis of Viral Vector and Plasmid DNA
• 9.3 Labor Cost Analysis of Viral Vector and Plasmid DNA
• 9.4 Manufacturing Expenses Analysis of Viral Vector and Plasmid DNA

Chapter 10 Marketing Status Analysis of Viral Vector and Plasmid DNA

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources